Results 91 to 100 of about 306,084 (179)

Endotrophin Measured by PRO‐C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Background & Aims Prognostic non‐invasive tests for liver‐related events in compensated cirrhosis are needed. Endotrophin, a fragment of type VI alpha 3 collagen involved in fibrosis and inflammation, has been associated with adverse outcomes in several chronic diseases.
Thomas Wiggers, Emilie Toft Skovgaard, Morten Karsdal, Jens Juul Holst, Frederik Christiansen, Andressa de Zawadzki, Diana Julie Leeming, Keyur Patel   +7 more
wiley   +1 more source

Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial

Annals of Hepatology, 2012
Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients ...
Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, José R.B. Pernambuco, Suelene S. Pedrosa, Rosângela Teixeira, Hoel Sette, Jr, Fernando Tatsch   +12 more
doaj   +1 more source

Chronic hepatitis b with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy

Journal of Infection in Developing Countries, 2011
Interferon alpha is a molecule frequently used in the treatment of chronic hepatitis B, C, and D, with immunomodulatory and antiviral activity. It is also used in some cancer types. It has been widely claimed that interferon alpha triggers autoimmunity,
Sukran Kose, Ayhan Gozaydin, Gulgun Akkoclu, Gulfem Ece   +3 more
doaj   +1 more source

Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a. [PDF]

, 2004
S100B belongs to a family of calcium-binding proteins implicated in intracellular and extracellular regulatory activities. This study of serum S100B in primary progressive multiple sclerosis (PPMS) is based on data obtained from a randomized, controlled ...
Lim, Ee Tuan, Leary, Siobhan M, Geoff Keir, Petzold, Axel, Thompson, Alan J, Gavin Giovannoni, Siobhan M Leary, Altmann, Daniel R, Keir, Geoff, Ee Tuan Lim, David H Miller, Ed J Thompson, Giovannoni, Gavin, Miller, David H, Alan J Thompson, Daniel R Altmann, Thompson, Ed J, Axel Petzold   +17 more
core   +2 more sources

Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands [PDF]

, 1992
Cytomegalovirus (CMV), similar to other members of the Herpesviridae family, can establish both persistent and latent infections. Each of the CMVs that are found in many animal species replicates in the salivary gland, and oral secretion represents a ...
Pavic, Ivica, Koszinowski, Ulrich H., Koszinowski, U H, Lucin, Pero, Polic, Bojan, Jonjic, Stipan   +5 more
core   +1 more source

Bunyaviruses and the type I interferon system [PDF]

, 2009
The family Bunyaviridae contains more than 350 viruses that are distributed throughout the world. Most members of the family are transmitted by arthopods, and several cause disease in man, domesticated animals and crop plants. Despite being recognized as
Richard M. Elliott, Weber, F., Richard Elliott, Richard M. Elliott, Elliott, Richard Michael, Friedemann Weber, Weber, F, Elliott, R.M.   +7 more
core   +1 more source

Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy

, 2001
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.
Ramadori, Giuliano, Meier, V., Braun, F., Wietzke-Braun, Perdita   +3 more
core   +2 more sources

Sertraline treatment of interferon-alfa-induced depressive disorder

, 2000
Interferon alfa therapy for chronic hepatitis C infection is commonly associated with neuropsychiatric symptoms, including depression. These side effects may necessitate reduction or even cessation of interferon alfa, hut there is little information ...
Macdonald, G. A., Schramm, T. M., Cooksley, W. G. E., Lawford, B.   +3 more
core  

Myasthenia gravis during interferon alfa therapy

, 1995
Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment ...
Servidei, Serenella, Evoli, Amelia, Batocchi, Anna Paola   +2 more
core  

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

, 2007
BACKGROUND: Interferon alfa is widely used for metastatic renal-cell carcinoma but has limited efficacy and tolerability. Temsirolimus, a specific inhibitor of the mammalian target of rapamycin kinase, may benefit patients with this disease.
Lesovoy, Vladimir, Hudes, Gary, Dutcher, Janice, Bodrogi, Istvan, Gokmen, Erhan, Barbarash, Olga, McDermott, David, Lustgarten, Stephanie, Tomczak, Piotr, Figlin, Robert, O'Toole, Timothy, Staroslawska, Elzbieta, Sosman, Jeffrey, Kovacevic, Zoran, Schmidt-Wolf, Ingo G. H., Motzer, Robert J., Kapoor, Anil, Moore, Laurence, Carducci, Michael   +18 more
core   +1 more source